K-phos Tablet, Coated
NDC Package 0486-1134-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

K-phos (potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous) tablets is a medication contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia. This formulation utilizes a tablet, coated delivery system. Marketed by Beach Products, Inc., this product is identified by NDC 0486-1134.

Identification & Billing

NDC Package Code
0486-1134-01
Package Description
100 TABLET, COATED in 1 BOTTLE
Product Code
0486-1134
11-Digit Billing Format
00486113401
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 209224 - K-Phos No 2 305 MG / 700 MG Oral Tablet
  • RxCUI: 209224 - potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet [K-Phos No 2]
  • RxCUI: 209224 - K+ phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]
  • RxCUI: 209224 - K-Phos No 2 (potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG) Oral Tablet
  • RxCUI: 209224 - Pot phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]

Clinical Specifications

Proprietary Name
K-phos No. 2
Non-Proprietary Name
Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous
Substance Name
Potassium Phosphate, Monobasic; Sodium Phosphate, Monobasic, Anhydrous
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Regulatory & Marketing

Labeler Name
Beach Products, Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
05-09-1978
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0486-1134-01 identifies a specific commercial package of 100 tablet, coated in 1 bottle of K-phos No. 2, a human prescription drug labeled by Beach Products, Inc.. This tablet, coated is formulated for oral use and contains potassium phosphate, monobasic; sodium phosphate, monobasic, anhydrous as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Beach Products, Inc. on May 09, 1978. The current certification is valid through December 31, 2026.

How is this Beach Products, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00486113401. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0486-1134-01
11-Digit CMS (5-4-2)
00486-1134-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.